Monthly Archives

November 2019

FDA Approves Global Blood Therapeutics Sickle Cell Disease Drug

  • November 26, 2019
  • Burrell Jacqueline

(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to... Continue Reading

CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data

  • November 19, 2019
  • Burrell Jacqueline

Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading

US approves new drug to manage sickle cell disease

  • November 18, 2019
  • Burrell Jacqueline

By LINDA A. JOHNSON | November 15, 2019 |  APNews.com U.S. regulators on Friday approved a new medicine that can help... Continue Reading

Novartis Adakveo approved by FDA for Sickle Cell Disease

  • November 16, 2019
  • Burrell Jacqueline

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading



				
Powered by DoJiggy Nonprofit Website Hosting
production52a9